Join Growin Stock Community!

111, inc.YI.US Overview

US StockConsumer Defensive
(No presentation for YI)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

YI AI Insights

YI Overall Performance

YI AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

YI Recent Performance

-1.39%

111, inc.

-1.34%

Avg of Sector

-0.31%

S&P500

YI PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

YI Key Information

YI Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2026Q1
2026Q2
2026Q3
2026Q4
2027Q1

YI Profile

111, Inc. operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2B and B2C. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services that include online consultation services and electronic prescription services to consumers. It offers prescription and over-the counter drugs, including western and traditional Chinese medicines; nutritional supplements, such as vitamins and dietary products; contact lenses; medical supplies and devices comprising bandages and thermometers; and personal care products consisting of skin care, birth control, and sexual wellness products; and baby products. The company also operates an online marketplace where third-party sellers can directly sell to pharmacies; provides online loan application services to the clients of 1 Pharmacy, which include pharmacies and wholesalers; and data and supply chain integration services. As of December 31, 2021, it operated 14 offline retail pharmacies under the Yi Hao Pharmacy brand name in Guangzhou, Tianjin, Kunshan, Chongqing, and Wuhan provinces. In addition, the company offers warehousing, logistics, procurement, research and development, and consulting services; and software development and information technology support services. It serves pharmacies, pharmaceutical companies and distributors, medical professionals, and insurance companies. The company was formerly known as New Peak Group and changed its name to 111, Inc. in April 2018. 111, Inc. was founded in 2010 and is headquartered in Shanghai, the People's Republic of China.

Price of YI

YI FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

YI Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-8.08
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
0.01
PB Ratio
-
Price-to-FCF
1.68
METRIC
VALUE
vs. INDUSTRY
Gross Margin
5.60%
Net Margin
-0.52%
Revenue Growth (YoY)
-7.36%
Profit Growth (YoY)
-9.51%
3-Year Revenue Growth
-3.59%
3-Year Profit Growth
-4.12%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-8.08
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
0.01
PB Ratio
-
Price-to-FCF
1.68
Gross Margin
5.60%
Net Margin
-0.52%
Revenue Growth (YoY)
-7.36%
Profit Growth (YoY)
-9.51%
3-Year Revenue Growth
-3.59%
3-Year Profit Growth
-4.12%

  • When is YI's latest earnings report released?

    The most recent financial report for 111, inc. (YI) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating YI's short-term business performance and financial health. For the latest updates on YI's earnings releases, visit this page regularly.

  • What is the operating profit of YI?

    According to the latest financial report, 111, inc. (YI) reported an Operating Profit of -2.3M with an Operating Margin of -0.08% this period, representing a decline of 196.84% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is YI's revenue growth?

    In the latest financial report, 111, inc. (YI) announced revenue of 3B, with a Year-Over-Year growth rate of -16.66%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much debt does YI have?

    As of the end of the reporting period, 111, inc. (YI) had total debt of 204.73M, with a debt ratio of 0.08. Short-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.

  • How much cash does YI have?

    At the end of the period, 111, inc. (YI) held Total Cash and Cash Equivalents of 527.55M, accounting for 0.21 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does YI go with three margins increasing?

    In the latest report, 111, inc. (YI) did not achieve the “three margins increasing” benchmark, with a gross margin of 5.9%%, operating margin of -0.08%%, and net margin of -0.4%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess YI's profit trajectory and future growth potential.

  • Is YI's EPS continuing to grow?

    According to the past four quarterly reports, 111, inc. (YI)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at -0.2. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of YI?

    111, inc. (YI)'s Free Cash Flow (FCF) for the period is 38.08M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 65.34% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.

  • What are the PEG ratio and PE ratio of YI?

    The latest valuation data shows 111, inc. (YI) has a Price-To-Earnings (PE) ratio of -3.1 and a Price/Earnings-To-Growth (PEG) ratio of 0.43. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.